{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:18:22Z","timestamp":1789827502684,"version":"4.0.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bone.2020.115729","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T09:49:33Z","timestamp":1604051373000},"page":"115729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Hip disease in Mucopolysaccharidoses and Mucolipidoses: A review of mechanisms, interventions and future perspectives"],"prefix":"10.1016","volume":"143","author":[{"given":"Esmee","family":"Oussoren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet A.E.M.","family":"Wagenmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"van der Meijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.M. Pim","family":"Pijnappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.G.","family":"Ruijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115729_bb0005","series-title":"The Metabolic Bases of Inherited Disease","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.bone.2020.115729_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138622","article-title":"A multiplex assay for the diagnosis of mucopolysaccharidoses and mucolipidoses","volume":"10","author":"Langereis","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2020.115729_bb0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2016.12.010","article-title":"Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2020.115729_bb0020","first-page":"283","article-title":"Mucolipidosis II (I cell disease): present status of knowledge","volume":"11","author":"Leroy","year":"1975","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.bone.2020.115729_bb0025","first-page":"1542","article-title":"Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options","volume":"2011","author":"Oussoren","year":"1812","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bone.2020.115729_bb0030","series-title":"Kimata K","author":"Esko","year":"2009"},{"key":"10.1016\/j.bone.2020.115729_bb0035","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1039\/c2mb25021g","article-title":"Proteoglycan sequence","volume":"8","author":"Li","year":"2012","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.bone.2020.115729_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10719-015-9642-2","article-title":"Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling","volume":"33","author":"Gulati","year":"2016","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bone.2020.115729_bb0045","doi-asserted-by":"crossref","first-page":"31437","DOI":"10.1074\/jbc.271.49.31437","article-title":"Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. I. Purification and subunit structure","volume":"271","author":"Bao","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115729_bb0050","doi-asserted-by":"crossref","first-page":"36141","DOI":"10.1074\/jbc.M509008200","article-title":"The alpha- and beta-subunits of the human UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase [corrected] are encoded by a single cDNA","volume":"280","author":"Kudo","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115729_bb0055","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1016\/S0021-9258(19)69430-5","article-title":"UDP-N-acetylglucosamine:glycoprotein N-acetylglucosamine-1-phosphotransferase. Proposed enzyme for the phosphorylation of the high mannose oligosaccharide units of lysosomal enzymes","volume":"256","author":"Reitman","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115729_bb0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI5826","article-title":"Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC)","volume":"105","author":"Raas-Rothschild","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115729_bb0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.a.30868","article-title":"Missense mutations in N-acetylglucosamine-1-phosphotransferase alpha\/beta subunit gene in a patient with mucolipidosis III and a mild clinical phenotype","volume":"137A","author":"Tiede","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2020.115729_bb0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0006-291X(81)91177-3","article-title":"Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts","volume":"98","author":"Hasilik","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2020.115729_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/pupt.2001.0296","article-title":"Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness","volume":"14","author":"Lever","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bone.2020.115729_bb0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2020.115729_bb0085","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1073\/pnas.1110629108","article-title":"Modulation of canonical Wnt signaling by the extracellular matrix component biglycan","volume":"108","author":"Berendsen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2020.115729_bb0090","series-title":"Tomatsu S","author":"Melbouci","year":"2018"},{"key":"10.1016\/j.bone.2020.115729_bb0095","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s10545-018-0212-1","article-title":"Craniosynostosis affects the majority of mucopolysaccharidosis patients and can contribute to increased intracranial pressure","volume":"41","author":"Oussoren","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2020.115729_bb0100","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/jmg.29.11.834","article-title":"An atypical form of mucolipidosis III","volume":"29","author":"Freisinger","year":"1992","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2020.115729_bb0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/014107689909200508","article-title":"Orthopaedic management in four cases of mucolipidosis type III","volume":"92","author":"Hetherington","year":"1999","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.bone.2020.115729_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01202412-200001000-00014","article-title":"Orthopaedic manifestations of mucolipidosis III: an illustrative case","volume":"9","author":"Haddad","year":"2000","journal-title":"J Pediatr Orthop B"},{"key":"10.1016\/j.bone.2020.115729_bb0115","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1023\/A:1022935115323","article-title":"The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment","volume":"25","author":"Robinson","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2020.115729_bb0120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1440-1754.2010.01715.x","article-title":"The natural history and osteodystrophy of mucolipidosis types II and III","volume":"46","author":"David-Vizcarra","year":"2010","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.bone.2020.115729_bb0125","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.reuma.2013.10.001","article-title":"Skeletal deformities in mucolipidosis III","volume":"10","author":"Pantoja Zarza","year":"2014","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.bone.2020.115729_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jmg.2009.067736","article-title":"Phenotype and genotype in mucolipidoses II and III alpha\/beta: a study of 61 probands","volume":"47","author":"Cathey","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2020.115729_bb0135","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2106\/JBJS.O.00601","article-title":"Progression of hip dysplasia in mucopolysaccharidosis type I Hurler after successful hematopoietic stem cell transplantation","volume":"98","author":"Langereis","year":"2016","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2020.115729_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-016-0470-7","article-title":"Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation","volume":"11","author":"Schmidt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.bone.2020.115729_bb0145","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/BPO.0000000000000463","article-title":"Characterization of hip morphology in children with mucopolysaccharidosis types I and II","volume":"36","author":"Ashby","year":"2015","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0150","article-title":"Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey","volume":"2","author":"Link","year":"2010","journal-title":"Orthop Rev (Pavia)"},{"key":"10.1016\/j.bone.2020.115729_bb0155","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/1757-1626-1-410","article-title":"Progressive acetabular dysplasia in a boy with mucopolysaccharoidosis type IV A (Morquio syndrome): a case report","volume":"1","author":"Al Kaissi","year":"2008","journal-title":"Cases J"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2020.115729_bb0160","first-page":"141","article-title":"Morquio A syndrome: diagnosis and current and future therapies","volume":"12","author":"Tomatsu","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.bone.2020.115729_bb0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ymgme.2017.05.008","article-title":"A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI","volume":"121","author":"Oussoren","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2020.115729_bb0170","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00247-016-3673-0","article-title":"Early characteristic radiographic changes in mucolipidosis II","volume":"46","author":"Lai","year":"2016","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.bone.2020.115729_bb0175","series-title":"Maas M","author":"Oussoren","year":"2018"},{"key":"10.1016\/j.bone.2020.115729_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030728","article-title":"Hip morphology in mucolipidosis type II","volume":"9","author":"Ammer","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2020.115729_bb0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Montano","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2020.115729_bb0190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.reuma.2014.03.006","article-title":"Health related quality of life in rheumatoid arthritis, osteoarthritis, diabetes mellitus, end stage renal disease and geriatric subjects. Experience from a General Hospital in Mexico","volume":"11","author":"Ambriz Murillo","year":"2015","journal-title":"Reumatol Clin"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2020.115729_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10198-016-0787-0","article-title":"Social\/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe","volume":"17","author":"P\u00e9ntek","year":"2016","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.bone.2020.115729_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1750-1172-8-101","article-title":"The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life","volume":"8","author":"Raluy-Callado","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bone.2020.115729_bb0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10545-014-9737-0","article-title":"Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey","volume":"38","author":"Brands","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2020.115729_bb0210","doi-asserted-by":"crossref","first-page":"115359","DOI":"10.1016\/j.bone.2020.115359","article-title":"Growth plate skeletal stem cells and their transition from cartilage to bone","volume":"136","author":"Matsushita","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115729_bb0215","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature01657","article-title":"Developmental regulation of the growth plate","volume":"423","author":"Kronenberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2020.115729_bb0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ocl.2005.12.001","article-title":"Growth and development of the child\u2019s hip","volume":"37","author":"Lee","year":"2006","journal-title":"Orthop Clin North Am"},{"key":"10.1016\/j.bone.2020.115729_bb0225","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/BPO.0000000000001120","article-title":"Analysis of acetabular ossification from the triradiate cartilage and secondary centers","volume":"38","author":"Parvaresh","year":"2018","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00003086-198712000-00007","article-title":"Natural history of congenital hip dislocation (CDH) and hip dysplasia","author":"Weinstein","year":"1987","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2020.115729_bb0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2106\/00004623-197860050-00001","article-title":"Growth and development of the acetabulum in the normal child. Anatomical, histological, and roentgenographic studies","volume":"60","author":"Ponseti","year":"1978","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2020.115729_bb0240","unstructured":"Goldstein RY, Kaye ID, Slover J, Feldman D. Hip dysplasia in the skeletally mature patient. Bull Hosp Jt Dis (2013) 2014;72: 28\u201342."},{"key":"10.1016\/j.bone.2020.115729_bb0245","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00003086-198110000-00002","article-title":"Patterns of deformity of the developing hip","author":"Siffert","year":"1981","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"9","key":"10.1016\/j.bone.2020.115729_bb0250","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00264-020-04600-2","article-title":"Hip morphology in mucopolysaccharidosis type IVA through radiograph, magnetic resonance imaging and arthrogram assessment","volume":"44","author":"Miao","year":"2020","journal-title":"Int. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0255","doi-asserted-by":"crossref","unstructured":"Langereis EJ, Borgo A, Crushell E, Harmatz PR, van Hasselt PM, Jones SA, Kelly PM, Lampe C, van der Lee JH, Odent T, Sakkers R, Scarpa M, Schafroth MU, Struijs PA, Valayannopoulos V, White KK, Wijburg FA. Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure. Orphanet J Rare Dis 2013;8: 155.","DOI":"10.1186\/1750-1172-8-155"},{"key":"10.1016\/j.bone.2020.115729_bb0260","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/pd.1970121207","article-title":"Fetal presentation of Morquio disease type A","volume":"12","author":"Beck","year":"1992","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.bone.2020.115729_bb0265","first-page":"305","article-title":"Hurler syndrome with special reference to histologic abnormalities of the growth plate","author":"Silveri","year":"1991","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2020.115729_bb0270","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00003086-197909000-00040","article-title":"Ultrastructure of cartilage in heritable disorders of connective tissue","author":"Nogami","year":"1979","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2020.115729_bb0275","first-page":"855","article-title":"The pathology of gargoylism; report of a case and review of the literature","volume":"24","author":"Strauss","year":"1948","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2020.115729_bb0280","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archpedi.1948.02030030249002","article-title":"Gargoylism; study of pathologic lesions and clinical review of 12 cases","volume":"76","author":"Lindsay","year":"1948","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.bone.2020.115729_bb0285","first-page":"283","article-title":"Bone changes of mucolipidosis II at different ages. Postmortem study of three cases","author":"Pazzaglia","year":"1992","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2020.115729_bb0290","doi-asserted-by":"crossref","unstructured":"Ho CC, Tsung LL, Liu KT, Poon WT. GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha\/beta: a case report. BMC Med Genet 2018;19: 162.","DOI":"10.1186\/s12881-018-0679-5"},{"key":"10.1016\/j.bone.2020.115729_bb0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00310256","article-title":"Growth plate pathology in feline mucopolysaccharidosis VI","volume":"57","author":"Abreu","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115729_bb0300","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1073\/pnas.93.16.8214","article-title":"Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI","volume":"93","author":"Evers","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2020.115729_bb0305","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2009.03.005","article-title":"Mechanism of shortened bones in mucopolysaccharidosis VII","volume":"97","author":"Metcalf","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2020.115729_bb0310","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymgme.2018.04.014","article-title":"Delayed development of ossification centers in the tibia of prenatal and early postnatal MPS VII mice","volume":"124","author":"Jiang","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2020.115729_bb0315","first-page":"109","article-title":"Radiologic and neuroradiologic findings in the mucopolysaccharidoses","volume":"3","author":"Lachman","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.bone.2020.115729_bb0320","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/BPO.0b013e3181649e25","article-title":"Mobility in Hurler syndrome","volume":"28","author":"Taylor","year":"2008","journal-title":"J. Pediatr. Orthop."},{"issue":"9","key":"10.1016\/j.bone.2020.115729_bb0325","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/BPO.0000000000000858","article-title":"Hip morphology in MPS-1H patients: an MRI-based study","volume":"38","author":"Breyer","year":"2018","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0330","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/bpo.0b013e31815a6007","article-title":"The use of computed tomography to assess acetabular morphology in Morquio-Brailsford syndrome","volume":"27","author":"Borowski","year":"2007","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0335","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00256-013-1797-y","article-title":"Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose","volume":"43","author":"Lachman","year":"2014","journal-title":"Skelet. Radiol."},{"key":"10.1016\/j.bone.2020.115729_bb0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MCD.0000000000000249","article-title":"Does the clinical phenotype of mucolipidosis-IIIgamma differ from its alphabeta counterpart?: supporting facts in a cohort of 18 patients","volume":"28","author":"Nampoothiri","year":"2019","journal-title":"Clin. Dysmorphol."},{"key":"10.1016\/j.bone.2020.115729_bb0345","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.gene.2017.11.052","article-title":"Mucolipidosis type III gamma: three novel mutation and genotype-phenotype study in eleven patients","volume":"642","author":"Tuysuz","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.bone.2020.115729_bb0350","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bone.2020.115729_bb0355","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1248\/bpb.b17-00059","article-title":"Supplemented chondroitin sulfate and hyaluronic acid suppress mineralization of the chondrogenic cell line, ATDC5, via direct inhibition of alkaline phosphatase","volume":"40","author":"Kudo","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bone.2020.115729_bb0360","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/BPO.0b013e31821f5ee9","article-title":"Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III)","volume":"31","author":"White","year":"2011","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0365","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2013.03.004","article-title":"High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study","volume":"109","author":"de Ruijter","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2020.115729_bb0370","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1074\/mcp.M112.026609","article-title":"Quantitative phosphoproteomics analysis reveals broad regulatory role of heparan sulfate on endothelial signaling","volume":"12","author":"Qiu","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"4","key":"10.1016\/j.bone.2020.115729_bb0375","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.3390\/molecules20046342","article-title":"Heparin\/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use","volume":"20","author":"Chiodelli","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bone.2020.115729_bb0380","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00247-019-04504-3","article-title":"Imaging of developmental dysplasia of the hip: ultrasound, radiography and magnetic resonance imaging","volume":"49","author":"Barrera","year":"2019","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.bone.2020.115729_bb0385","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"Simonaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2020.115729_bb0390","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age\u2014a sibling control study","volume":"77","author":"McGill","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bone.2020.115729_bb0395","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ymgme.2011.08.029","article-title":"Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI","volume":"104","author":"Furujo","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2020.115729_bb0400","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15017850","article-title":"Impact of early enzyme-replacement therapy for mucopolysaccharidosis VI: results of a long-term follow-up of Brazilian siblings","volume":"15","author":"Franco","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.bone.2020.115729_bb0405","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bone.2020.115729_bb0410","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1302\/0301-620X.76B6.7983131","article-title":"Bone-marrow transplantation in Hurler\u2019s syndrome. Effect on skeletal development","volume":"76","author":"Field","year":"1994","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.bone.2020.115729_bb0415","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1023\/A:1005447232027","article-title":"Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up","volume":"22","author":"Herskhovitz","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2020.115729_bb0420","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1750-1172-8-134","article-title":"Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome","volume":"8","author":"Jester","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bone.2020.115729_bb0425","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2020.115729_bb0430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/BPO.0000000000000385","article-title":"A long-term retrospective evaluation of functional and radiographic outcomes of pediatric hip surgery in Hurler syndrome","volume":"36","author":"Kennedy","year":"2016","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0435","first-page":"50","article-title":"Hip dysplasia in Mucopolysaccharidosis type IVA (Morquio A syndrome) treated by proximal femoral valgization osteotomy: a case report","volume":"8","author":"Berger-Groch","year":"2018","journal-title":"J Orthop Case Rep"},{"key":"10.1016\/j.bone.2020.115729_bb0440","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/0189-6725.182563","article-title":"Corrections of diverse forms of lower limb deformities in patients with Mucopolysaccharidosis type IVA (Morquio syndrome)","volume":"13","author":"Al Kaissi","year":"2016","journal-title":"Afr. J. Paediatr. Surg."},{"key":"10.1016\/j.bone.2020.115729_bb0445","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13052-018-0557-y","article-title":"Orthopaedic challenges for mucopolysaccharidoses","volume":"44","author":"Borgo","year":"2018","journal-title":"Ital. J. Pediatr."},{"issue":"Suppl. 5","key":"10.1016\/j.bone.2020.115729_bb0450","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"White","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bone.2020.115729_bb0455","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1302\/0301-620X.92B2.23104","article-title":"Bilateral hip replacement in three patients with lysosomal storage disease: Mucopolysaccharidosis type IV and Mucolipidosis type III","volume":"92","author":"Lewis","year":"2010","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.bone.2020.115729_bb0460","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/BPO.0b013e31829abfe0","article-title":"Hip dysplasia in patients with Hurler syndrome (mucopolysaccharidosis type 1H)","volume":"33","author":"Thawrani","year":"2013","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0465","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2020.115729_bb0470","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0049-0172(99)80021-3","article-title":"The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment","volume":"28","author":"Ghosh","year":"1999","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bone.2020.115729_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100882","article-title":"Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment","volume":"9","author":"Frohbergh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2020.115729_bb0480","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2020.115729_bb0485","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2935","article-title":"Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells","volume":"12","author":"Ghosh","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bone.2020.115729_bb0490","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-5347(05)64909-9","article-title":"Sodium pentosan polysulfate reduces urothelial responses to inflammatory stimuli via an indirect mechanism","volume":"168","author":"Sadhukhan","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.bone.2020.115729_bb0495","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10545-016-9974-5","article-title":"Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study","volume":"39","author":"Hennermann","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2020.115729_bb0500","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2165\/00003495-200666110-00001","article-title":"Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery","volume":"66","author":"Eriksson","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.bone.2020.115729_bb0505","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0091270008323751","article-title":"Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin","volume":"48","author":"Myers","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2020.115729_bb0510","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/17425247.2015.966682","article-title":"Gene therapy for neurologic manifestations of mucopolysaccharidoses","volume":"12","author":"Wolf","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.bone.2020.115729_bb0515","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.omtm.2017.07.004","article-title":"Non-clinical safety and efficacy of an AAV2\/8 vector administered intravenously for treatment of Mucopolysaccharidosis type VI","volume":"6","author":"Ferla","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.bone.2020.115729_bb0520","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/humc.2017.109","article-title":"Differential prevalence of antibodies against adeno-associated virus in healthy children and patients with Mucopolysaccharidosis III: perspective for AAV-mediated gene therapy","volume":"28","author":"Fu","year":"2017","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.bone.2020.115729_bb0525","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/BPO.0b013e318259fe57","article-title":"The lower extremity in Morquio syndrome","volume":"32","author":"Dhawale","year":"2012","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2020.115729_bb0530","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00003086-197501000-00004","article-title":"Shelf operation for congenital subluxation and dislocation of the hip","author":"Bickel","year":"1975","journal-title":"Clin. Orthop. Relat. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220305172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220305172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:51:03Z","timestamp":1757613063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220305172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":106,"alternative-id":["S8756328220305172"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115729","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hip disease in Mucopolysaccharidoses and Mucolipidoses: A review of mechanisms, interventions and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115729"}}